Cardiac tissue engineering and regeneration using cell-based therapy

  • Shum-Tim D
  • Ridwan K
  • Alrefai M
 et al. 
  • 3


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Stem cell therapy and tissue engineering represent a forefront of current research in the treatment of heart disease. With these technologies, advancements are being made into therapies for acute ischemic myocardial injury and chronic, otherwise nonreversible, myocardial failure. The current clinical management of cardiac ischemia deals with reestablishing perfusion to the heart but not dealing with the irreversible damage caused by the occlusion or stenosis of the supplying vessels. The applications of these new technologies are not yet fully established as part of the management of cardiac diseases but will become so in the near future. The discussion presented here reviews some of the pioneering works at this new frontier. Key results of allogeneic and autologous stem cell trials are presented, including the use of embryonic, bone marrow-derived, adipose-derived, and resident cardiac stem cells.

Author-supplied keywords

  • cardiac surgery
  • cardiomyocytes
  • cell sheet and tissue engineering
  • heart
  • heart failure
  • myocardial ischemia
  • organoids
  • scaffolds
  • stem cells

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Dominique Shum-Tim

  • Khalid Ridwan

  • Mohammad Alrefai

  • John Connell

  • Arghya Paul

  • Divya Murali

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free